secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0001437749-22-010106
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 2.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Q1 sales $39.6M (+13% organic), EPS $0.27; guides FY $160-164M, closes French factory
--------------------------------------------------------------------------------

- Q1 sales $39.6M, +10% YoY (+13% organic); net income $6.0M, +2%; EPS $0.27, -4%.
- FY 2022 guidance: sales $160-164M (+5%/+8% org), EPS $1.10-$1.20; lowered due to stronger USD.
- Quarterly dividend $0.125/share, payable June 2, 2022 to shareholders of record May 17, 2022.
- Committed to close St. Etienne, France factory by June 30, 2022; ~$3.1M special charges in 2022, ~$1M annual op income benefit from 2023.
- Agreed to buy out Korean distributor JiSang for $540k; direct-to-hospital in Korea starting January 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000143774922010106/0001437749-22-010106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000143774922010106/lmat20220428_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-010106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer